Orthopedic Use of BPC 157 Sports Med Review After being placed into FDA Category 2 in 2023, several widely discussed peptides faced restricted pathways for regulated compounding. This shift pushed demand toward unregulated markets and created significant uncertainty across the RFK Jr. & claimed regenerative peptides like BPC 157 The Niche FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA takes first step in possible reversal of ban on some peptides The Washington Post